Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Tepezza
Pharma
Viridian set for 1-on-1 vs. Amgen after FDA approval of Lumvoa
Viridian has secured an FDA nod for Lumvoa to treat the eye-bulging condition TED, triggering competition with Amgen’s blockbuster Tepezza.
Kevin Dunleavy
Jun 29, 2026 8:32am
Amgen awards Bradway with $24.7M pay package in ’25
Apr 8, 2026 10:45am
On-body injected version of Amgen's Tepezza measures up to IV
Apr 6, 2026 9:43am
Amgen's products from buyout of Horizon continue to struggle
May 2, 2025 8:18am
Amgen reaps Horizon buyout rewards in Q3, preps biosim launches
Oct 31, 2024 7:50am
Improved access helps Amgen's Tepezza to a sales increase
Aug 7, 2024 8:35am
